Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection

被引：4
|
作者：
Einsiedel, Hagen Graf [1 ]
Christiansen, Holger [1 ]
Wiegand, Johannes [2 ]
机构：
[1] Univ Leipzig, Abt Padiat Onkol Hamatol & Hamostaseol, Leipzig, Germany
[2] Univ Leipzig, Klin & Poliklin Gastroenterol & Rheumatol, Sekt Hepatol, Liebigstr 20, D-04103 Leipzig, Germany
来源：
PEDIATRIC INFECTIOUS DISEASE JOURNAL | 2016年 / 35卷 / 12期
关键词：
D O I：
10.1097/INF.0000000000001336
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1373 / 1373
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 OR 4 CHRONIC HEPATITIS C IN ENGLAND AND WALES
    Howells, R.
    Trehame, C.
    VALUE IN HEALTH, 2015, 18 (07) : A589 - A589
  • [22] Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection
    Ahmed, Ossama A.
    Kaisar, Hany H.
    Badawi, Rehab
    Hawash, Nehad
    Samir, Hossam
    Shabana, Sherif S. T.
    Fouad, Mohamed Hassan A.
    Rizk, Fatma H.
    Khodeir, Samy A.
    Abd-Elsalam, Sherief
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 295 - 298
  • [23] Treatment of Chronic Hepatitis C Genotype 3 With Ledipasvir and Sofosbuvir: An Observational Study
    Dar, Gulzar A.
    Yattoo, Ghulam N.
    Gulzar, Ghulam M.
    Sodhi, Jaswinder S.
    Gorka, Suresh
    Laway, Mushtaq A.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 11 (02) : 227 - 231
  • [24] Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1
    Kumari, Radhika
    Nguyen, Mindie H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 739 - 748
  • [25] Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis
    Rezaee-Zavareh, Mohammad Saeid
    Hesamizadeh, Khashayar
    Behnava, Bita
    Alavian, Seyed Moayed
    Gholami-Fesharaki, Mohammad
    Sharafi, Heidar
    ANNALS OF HEPATOLOGY, 2017, 16 (02) : 188 - 197
  • [26] Successful Treatment of Chronic Hepatitis C Virus Infection With Sofosbuvir and Ledipasvir in Renal Transplant Recipients
    Eisenberger, Ute
    Guberina, Hana
    Willuweit, Katharina
    Bienholz, Anja
    Kribben, Andreas
    Gerken, Guido
    Witzke, Oliver
    Herzer, Kerstin
    TRANSPLANTATION, 2017, 101 (05) : 980 - 986
  • [27] An evaluation of ledipasvir plus sofosbuvir for the treatment of chronic hepatitis C infection
    Balatow, Pearson
    Sandlin, Amber
    Cory, Theodore James
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (14) : 1839 - 1846
  • [28] HIGH THERAPEUTIC EFFICIENCY WITH LEDIPASVIR/SOFOSBUVIR FOR THE TREATMENT OF GENOTYPE 1 CHRONIC HEPATITIS C IN PORTUGAL
    Ferreira, D.
    Felix, J.
    Almeida, J.
    Mota, M.
    Afonso Silva, M.
    Silva, P.
    Vandewalle, B.
    Velosa, J.
    Marinho, R.
    Aldir, I
    Carvalho, A.
    Valente, C.
    Macedog, G.
    Sarmento e Castro, R.
    Pedroto, I
    VALUE IN HEALTH, 2015, 18 (07) : A578 - A578
  • [29] Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan
    Mizokami, Masashi
    Liu, Lauren J.
    Fujiyama, Naoto
    Littman, Marcus
    Yuan, Jason
    Sekiya, Tomoko
    Hedskog, Charlotte
    Ng, Leslie J.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) : 129 - 141
  • [30] Efficacy of Generic Sofosbuvir and Branded Daclatasvir Compared to Sofosbuvir and Ledipasvir Combination in the Treatment of Genotype 4 Hepatitis C Virus
    Joharji, H.
    Alkortas, D.
    Ajlan, A.
    Devol, E.
    Ahmed, M.
    Al-Khail, F. Aba
    Elsiesy, H.
    Alsebayel, M.
    Alashgar, H.
    Alquaiz, M.
    Alhamoudi, W.
    Almoshishir, A.
    Aljedai, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 624 - 624
12345